Company news
BetterLife Pharma Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
BetterLife Pharma Appoints LifeSci Advisors as Investor Relations Firm
October 27, 2026
BetterLife Pharma Appoints Professor Richard B. Lipton as Co-Chair of its Scientific Advisory Board
October 19, 2026
BetterLife Pharma Appoints Sheila Leitzinger as Head of Clinical Operations
October 15, 2026
BetterLife Pharma Establishes Scientific Advisory Board for Headache Program; Professor Peter Goadsby Appointed Co-Chair
October 14, 2026
BetterLife Pharma Addresses Notice of Civil Claim Filed by Steven Sangha
October 9, 2026
Kaplan Fox Reminds Better Home & Finance Holding Company (BETR) Investors with Significant Losses to Seek a Leadership Role Before Deadline on November 20, 2026
October 1, 2026
BetterLife Pharma Announces Rescheduling and Reclassification of Annual General Meeting to Annual General and Special Meeting
September 29, 2026
Better Home & Finance (BETR) Faces Securities Class Action Amid 75% Sequential Increase in Net Loss, Dimmed Loan Volume Prospects
September 28, 2026
BetterLife Pharma Inc. Announces Closing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants
September 17, 2026
Egan-Jones Recommends Shareholders Vote FOR the Garg Group's Proposals on the GREEN Consent Card
September 16, 2026
Garg Group Files Consent Materials Explaining Why Better Shareholders Should Vote to Oust Renegade Board Members After Share Price and Market Cap Plummet Under New Leadership's Tenure
September 14, 2026
BetterLife Pharma Inc. Announces Filing of Final Prospectus for US$100 Million Public Offering of Common Shares and Pre-Funded Warrants
September 11, 2026
BetterLife Pharma Appoints Charles Duncan as Director and Chair of the Audit Committee
August 31, 2026
BetterLife Pharma Inc. Announces Pricing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants
August 28, 2026
BetterLife Pharma Inc. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
August 24, 2026
BetterLife Pharma Appoints Mahan Chehrenama, DO, as Chief Medical Officer
August 19, 2026
BetterLife Pharma Prioritizes BETR-001 to Lead in Migraine and Headache Disorders, Targeting a Clinically Validated, FDA-Precedented Serotonergic Mechanism
July 13, 2026
BetterLife Pharma Announces Appointment of John W. LaRocca to Board of Directors and Audit Committee
July 9, 2026
BetterLife Engages Nucro-Technics to Complete the last GLP Toxicology Study of BETR-001 Required by the FDA for IND and Phase 1
July 6, 2026
BETR Investors Have Opportunity to Join Better Home & Finance Holding Company Fraud Investigation with the Schall Law Firm
June 27, 2026
BetterLife Engages Syner-G to Oversee GMP Manufacturing of BETR-001 for IND and Phase 1
June 25, 2026
BetterLife Pharma Secures CAD $2 Million in New Capital to Complete BETR-001 FDA IND Filing
June 22, 2026
Johnson Fistel Investigates Better Home & Finance Holding Company (BETR) After Recent Disclosures Concerning Loan Volume Target
June 12, 2026
Better and Coinbase Celebrate the First Token-backed Mortgage Fund Backed by Fannie Mae, Announce Official Product Launch Date
June 4, 2026
Annual Report for Fiscal Year Ending January 31, 2026 (Form 20-F)
June 1, 2026
BetterLife Pharma Announces Appointment of Doug Drysdale as Executive Chairman and Director
May 13, 2026
Better Home and Finance CEO, Chairman and Executive Team Purchase BETR Stock
April 8, 2026
Better and Coinbase Launch the First Token-Backed, Conforming Mortgage
March 26, 2026
HighTechLending and Better Expand Access to Home Equity Loans Through EquitySelect(TM) HELOC
March 25, 2026
ElevenLabs and Better.com Showcase Success of AI Loan Agent, Betsy(TM), at Scale in Financial Services
February 25, 2026
Better and Framework Ventures Announce Strategic Partnership to Enable Deployment of $500MM into Better via Sky's Stablecoin Ecosystem
February 23, 2026
BetterLife Pharma to Participate in YAFO Capital Access Asia Partnering Forum During JPM Week in San Francisco
January 6, 2026
BetterLife Pharma Announces Engagement with Shanghai-Based YAFO Capital
December 11, 2025
BetterLife Pharma Highlights Advantages of BETR-001 -- a Potent Neuroplastogen
December 4, 2025
BetterLife Pharma Highlights Advantages of BETR-001 - a Potent Neuroplastogen
December 4, 2025
BetterLife Pharma Welcomes Daniel Carcillo as Corporate Advisor
November 25, 2025
NEO Home Loans Appoints Bri Lees as Head of Marketing to Lead Brand and Growth Across Advisor-First Platform
October 23, 2025
BetterLife Pharma Appoints Doug Drysdale as Corporate Advisor
October 22, 2025
Finance of America Partners with Better.com to Leverage Tinman® AI Platform - Expanding Home Equity Product Suite for Homeowners Over 55
October 14, 2025
Finance of America Partners with Better.com to Expand Home Equity Offerings Through AI-Powered Tinman Platform
October 14, 2025
Top 1% Mortgage Veteran Jim Juergens Joins NEO Home Loans powered by Better to Leverage Scalable, Value-Driven Platform Positioned for Industry Disruption
October 7, 2025
NEO Home Loans Division Leader, Josh Mettle, Helps 82 Families in One Month Citing Technology Efficiencies and Team Synergy
August 18, 2025
USPTO Files ISSUE NOTIFICATION for BetterLife's BETR-001 Composition of Matter Patent
June 18, 2025
BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001
May 28, 2025
BetterLife Provides Comments on CEO’s Share Position Ownership and Recent BCSC Press Release
May 22, 2025
BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders
May 14, 2025
BetterLife Announces Debt Settlements
May 6, 2025
BetterLife Pharma Appoints Corporate Advisor
April 3, 2025
BetterLife Pharma Appoints New Director
March 31, 2025
BetterLife Announces Debt Conversions
March 10, 2025
Decks
- Investor Presentation (July 2026)
Investor deck · 18 slides · July 2026
- Investor Presentation (January 2023)
Investor deck · 15 slides · Jan 13, 2023
- Investor Presentation (August 2022)
Investor deck · 15 slides · August 2022
- Investor Presentation (December 2021)
Investor deck · 23 slides · December 2021
- Investor Presentation (May 2021)
Investor deck · 27 slides · May 26, 2021